ZA200704821B - Debriding composition from bromelain and methods of production thereof - Google Patents

Debriding composition from bromelain and methods of production thereof

Info

Publication number
ZA200704821B
ZA200704821B ZA200704821A ZA200704821A ZA200704821B ZA 200704821 B ZA200704821 B ZA 200704821B ZA 200704821 A ZA200704821 A ZA 200704821A ZA 200704821 A ZA200704821 A ZA 200704821A ZA 200704821 B ZA200704821 B ZA 200704821B
Authority
ZA
South Africa
Prior art keywords
bromelain
production
methods
debriding composition
debriding
Prior art date
Application number
ZA200704821A
Other languages
English (en)
Inventor
Gorecki Marian
Toren Amir
Original Assignee
Mediwound Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediwound Ltd filed Critical Mediwound Ltd
Publication of ZA200704821B publication Critical patent/ZA200704821B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200704821A 2004-11-22 2005-11-22 Debriding composition from bromelain and methods of production thereof ZA200704821B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16533404A IL165334A0 (en) 2004-11-22 2004-11-22 Debriding composition from bromelain and methods of producing same

Publications (1)

Publication Number Publication Date
ZA200704821B true ZA200704821B (en) 2008-11-26

Family

ID=36407550

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704821A ZA200704821B (en) 2004-11-22 2005-11-22 Debriding composition from bromelain and methods of production thereof

Country Status (18)

Country Link
US (2) US8119124B2 (pl)
EP (1) EP1824775B1 (pl)
JP (1) JP5053096B2 (pl)
KR (1) KR101235544B1 (pl)
CN (1) CN101297033B (pl)
AU (1) AU2005305461B2 (pl)
BR (1) BRPI0518050A (pl)
CA (1) CA2587951C (pl)
DK (1) DK1824775T3 (pl)
ES (1) ES2389810T3 (pl)
HK (1) HK1124639A1 (pl)
IL (2) IL165334A0 (pl)
MX (1) MX2007006074A (pl)
NO (1) NO337096B1 (pl)
PL (1) PL1824775T3 (pl)
PT (1) PT1824775E (pl)
WO (1) WO2006054309A2 (pl)
ZA (1) ZA200704821B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2588130T3 (pl) * 2010-06-25 2017-09-29 Shire Human Genetic Therapies, Inc. Dostarczanie środków terapeutycznych do OUN
US20140154235A1 (en) 2011-05-12 2014-06-05 Smith & Nephew Orthopaedics Ag Wound debridement compositions containing seaprose and methods of wound treatment using same
GB201110777D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110783D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
DK2734216T3 (en) * 2011-07-20 2018-11-19 Mediwound Ltd PROTEOLYTIC EXTRACT FROM BROMELAIN FOR TREATMENT OF CONNECTIVE TISSUE DISEASES
WO2013096337A1 (en) 2011-12-20 2013-06-27 Kci Licensing, Inc. Composition for enzymatic debridement
RU2014145270A (ru) 2012-05-11 2016-07-10 Смит & Невью, Инк. Способ и композиция для разрушения бактериальной биопленки
CN104884079B (zh) * 2012-11-14 2021-02-12 史密夫和内修公司 稳定的嗜热菌蛋白酶水凝胶
US20160101166A1 (en) 2014-10-10 2016-04-14 Rochal Industries, Llp Compositions and kits for treating pruritus and methods of using the same
LT6177B (lt) 2014-10-10 2015-07-27 Uab "Biocentras" Fermentų kompleksų išskyrimas iš steptomyces gougerotii 101, daugiafermentinių biopreparatų ruošimas bei taikymas
US9592280B2 (en) 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
US10238719B2 (en) 2014-10-10 2019-03-26 Rochal Industries, Llc Compositions and kits for enzymatic debridement and methods of using the same
CN104857187A (zh) * 2015-04-28 2015-08-26 李正 一种菠萝蛋白酶烧伤组织愈合药物
ES2909565T3 (es) * 2016-01-31 2022-05-09 Mediwound Ltd Composición desbridante para el tratamiento de heridas
AU2017252085B2 (en) * 2016-04-18 2021-09-16 Mediwound Ltd Methods of debridement of chronic wounds
CN109475609A (zh) 2016-07-27 2019-03-15 史密夫和内修有限公司 使用嗜热菌蛋白酶减少或消除来自表面的细菌生物膜
CN107913401A (zh) * 2016-10-08 2018-04-17 江阴市本特塞缪森生命科学研究院有限公司 胰蛋白酶产品及治疗妇科炎症的应用
US11413300B2 (en) 2017-01-30 2022-08-16 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
WO2020072982A1 (en) 2018-10-05 2020-04-09 Xenotherapeutics, Inc. Xenotransplantation products and methods
EP3945799A1 (en) 2019-03-25 2022-02-09 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non- human) donor and methods and products relating to same
WO2023159123A1 (en) * 2022-02-16 2023-08-24 Guild Associates Inc. Immobilized enzyme-based wound debridement

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197291A (en) 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
US4226854A (en) 1974-01-08 1980-10-07 Gerold K. V. Klein Debridement of devitalized tissue with hydrolytic enzyme product
US4307081A (en) * 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
US4329430A (en) * 1979-06-04 1982-05-11 Klein Gerold K V Enzyme mixture
US4320120A (en) 1979-10-22 1982-03-16 Zenyaku Kogyo Kabushiki Kaisha Extracts of Marsdenia cundurango Reichenbach fil
AU543965B2 (en) 1979-11-05 1985-05-09 Riker Laboratories, Inc. Method of enzymatic debridement
US4361551A (en) 1979-11-05 1982-11-30 Riker Laboratories, Inc. Method of enzymatic debridement
US4286064A (en) 1979-11-05 1981-08-25 Riker Laboratories, Inc. Process for isolating active debriding agent from bromelain
GB8724728D0 (en) 1987-10-22 1987-11-25 Genzyme Corp Cysteine proteinase
CA2046802C (en) 1990-08-15 2007-05-22 Donald Zane Fortney Compositions containing protease produced by vibrio and method of use in debridement and wound healing
IL103969A (en) * 1991-12-03 1997-01-10 Gerold K V Klein Proteolytic mixture containing escharase and method of isolating same
JP3255643B2 (ja) * 1991-12-03 2002-02-12 クライン，マーガレット エル． エスカラーゼを含む蛋白質分解混合物およびその分離方法
SG42846A1 (en) * 1992-06-30 1997-10-17 Cortecs Ltd Use of enzymes especially bromelain in the treatment of diarrhoea
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
US5387517A (en) 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5858964A (en) 1995-04-14 1999-01-12 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
US5830793A (en) 1995-12-28 1998-11-03 Micron Technology, Inc. Method of selective texfturing for patterned polysilicon electrodes
JP2001513636A (ja) * 1997-02-25 2001-09-04 コルテクス（ユーケイ）リミティッド ブロメラインの成分
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
US6803038B1 (en) * 1998-07-15 2004-10-12 Ursapharm Arzneimittel Gmbh Use of bromelaine proteases for inhibiting blood coagulation
GB9819138D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
US20030026794A1 (en) 2001-07-31 2003-02-06 Howard Fein Selective enzyme treatment of skin conditions
WO2003086275A2 (en) 2002-04-15 2003-10-23 Sun Pharmaceutical Industries Limited Preperation of desloratatine
WO2003090598A2 (en) * 2002-04-23 2003-11-06 Mediwound, Ltd. Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
EP2540831A3 (en) * 2006-08-17 2013-04-10 Monsanto Technology, LLC Transgenic plants with enhanced agronomic traits
EP2036978A1 (en) * 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions

Also Published As

Publication number Publication date
JP5053096B2 (ja) 2012-10-17
MX2007006074A (es) 2007-10-04
IL183184A (en) 2015-09-24
AU2005305461A1 (en) 2006-05-26
CA2587951A1 (en) 2006-05-26
HK1124639A1 (en) 2009-07-17
JP2008520651A (ja) 2008-06-19
ES2389810T3 (es) 2012-10-31
EP1824775A2 (en) 2007-08-29
BRPI0518050A (pt) 2008-10-28
DK1824775T3 (da) 2012-09-24
WO2006054309A2 (en) 2006-05-26
WO2006054309A3 (en) 2009-04-30
US8119124B2 (en) 2012-02-21
CA2587951C (en) 2015-03-31
US20120171187A1 (en) 2012-07-05
PT1824775E (pt) 2012-09-19
PL1824775T3 (pl) 2012-12-31
IL183184A0 (en) 2007-09-20
US20090148429A1 (en) 2009-06-11
AU2005305461B2 (en) 2011-01-27
CN101297033B (zh) 2012-05-30
EP1824775B1 (en) 2012-06-13
US8540983B2 (en) 2013-09-24
NO20073115L (no) 2007-08-13
NO337096B1 (no) 2016-01-18
KR20070091285A (ko) 2007-09-10
EP1824775A4 (en) 2011-01-26
IL165334A0 (en) 2006-01-15
CN101297033A (zh) 2008-10-29
KR101235544B1 (ko) 2013-02-21

Similar Documents

Publication Publication Date Title
HK1124639A1 (en) Debriding composition from bromelain and methods of production thereof
EP1919977A4 (en) POLY (BLOCK-PHOSPHONATO-ESTER) AND POLY (BLOCK-PHOSPHONATO-CARBONATE) AND MANUFACTURING METHOD THEREFOR
EP1883389A4 (en) LOW IRRITANT COMPOSITIONS AND METHODS OF MAKING SAME
IL187303A0 (en) Methods of prepering 3 - cyano - quinolines and intermediates made thereby
ZA200702069B (en) Silver-releasing articles and methods of manufacture
ZA200710148B (en) Methods of synthesizing substituted 3-cyanoquinolines and inermediates thereof
IL183017A0 (en) Stabilized ramipril compositions and methods of making
EP1786265A4 (en) NEW COMPOSITIONS AND PROCESSING METHODS
GB0505568D0 (en) Method of manufacture and associated component
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
ZA200709024B (en) Method of well treatment and construction
GB0520930D0 (en) Composition and method of use
GB0504657D0 (en) Compositions and methods of treatment
EP1802560A4 (en) HALOCOMB STATINE AND METHOD FOR THE PRODUCTION THEREOF
GB0406675D0 (en) Candles and methods of manufacture thereof
EP1791779A4 (en) SURFAX AND METHODS OF MAKING
GB0419175D0 (en) Method of treatment and compositions
GB0510483D0 (en) Cement and method of making cement
HU0400586D0 (en) Facing gacaparget and method of producing thereof
AU2004904405A0 (en) Compositions and Methods of Treatment
AU2004900511A0 (en) Compositions and Methods of Treatment
AU2005903854A0 (en) Compositions and methods of treatment
AU2005904259A0 (en) Compositions and methods of treatment
AU2005902426A0 (en) Fertilisers and methods of production
AU2005903621A0 (en) Composite Chute And Methods of Manufacture Thereof